First-in-Human Phase 1 Evaluation of the DegradaBALL Mesoporous Silica Nanoparticle Delivery System: An mRNA SARS-CoV-2 Vaccine Study in Healthy Korean Adult Volunteers
- DOI
- 10.2147/dddt.s631473
- Published
- 2026-10
- Container
- Drug Design, Development and Therapy
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2147/dddt.s631473,
title = {First-in-Human Phase 1 Evaluation of the DegradaBALL Mesoporous Silica Nanoparticle Delivery System: An mRNA SARS-CoV-2 Vaccine Study in Healthy Korean Adult Volunteers},
author = {Sooyoun Lee and Ki Young Huh and Kyung-Sang Yu and Dal-Hee Min and Cheolhee Won and In-Jin Jang},
year = {2026},
journal = {Drug Design, Development and Therapy},
doi = {10.2147/dddt.s631473},
url = {https://doi.org/10.2147/dddt.s631473}
}RIS
TY - JOUR TI - First-in-Human Phase 1 Evaluation of the DegradaBALL Mesoporous Silica Nanoparticle Delivery System: An mRNA SARS-CoV-2 Vaccine Study in Healthy Korean Adult Volunteers AU - Sooyoun Lee AU - Ki Young Huh AU - Kyung-Sang Yu AU - Dal-Hee Min AU - Cheolhee Won AU - In-Jin Jang PY - 2026 JO - Drug Design, Development and Therapy DO - 10.2147/dddt.s631473 UR - https://doi.org/10.2147/dddt.s631473 ER -
APA
Lee, S., Huh, K. Y., Yu, K., Min, D., Won, C., & Jang, I. (2026). First-in-Human Phase 1 Evaluation of the DegradaBALL Mesoporous Silica Nanoparticle Delivery System: An mRNA SARS-CoV-2 Vaccine Study in Healthy Korean Adult Volunteers. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s631473
Source records
- crossref · retrieved 2026-11-08T21:37:32.679Z